NVS Total Current Assets

Novartis AG Common Stock · Total Current Assets

NVS logo

NVS Total Current Assets

Latest reported$27.35B
NVS Quarterly Current Assets ($23.22B → $27.35B)
High-resolution chart · PNG

NVS total current assets history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Novartis AG Common Stock Total Current Assets — Quarterly (USD)
Period endingTotal Current Assets (USD)
27,351,110,000
26,607,000,000
30,460,000,000
28,198,000,000
25,939,000,000
25,108,000,000
29,704,000,000
31,264,000,000
25,693,000,000
26,447,000,000
30,480,939,982
45,660,000,000
33,493,000,000
32,114,000,000
36,910,089,322
36,954,000,000
38,142,000,000
37,236,000,000
45,718,000,000
26,253,000,000
23,808,000,000
22,198,000,000
29,673,000,000
28,973,000,000
23,882,000,000
23,098,000,000
29,503,872,483
26,675,000,000
28,320,000,000
52,448,000,000
35,563,000,000
34,113,000,000
32,065,000,000
33,051,000,000
28,208,000,000
27,466,000,000
26,538,000,000
25,766,000,000
24,931,000,000
25,883,000,000
23,722,000,000
22,993,000,000
22,845,000,000
24,045,000,000
24,746,000,000
25,710,000,000
37,561,000,000
36,788,000,000
34,973,000,000
29,688,000,000
30,542,000,000
28,770,000,000
26,845,000,000
26,795,000,000
28,004,000,000
26,148,000,000
26,122,000,000
25,787,000,000
24,084,000,000
25,563,000,000
26,629,000,000
29,100,000,000
26,685,000,000
27,716,000,000
38,667,000,000
35,800,000,000
33,691,000,000
30,440,000,000
27,172,000,000
22,482,000,000
20,881,000,000
23,297,000,000
32,085,000,000
26,287,000,000
27,430,000,000
28,682,000,000
20,637,000,000
21,334,000,000
21,404,000,000
20,973,000,000
19,795,000,000
21,915,000,000
21,443,000,000
18,476,000,000
20,114,000,000
22,263,000,000
24,611,000,000
21,556,000,000
21,628,000,000
21,208,000,000
22,273,000,000
20,515,000,000
20,162,000,000
21,880,000,000
20,870,000,000
18,124,000,000
20,755,000,000
20,640,000,000
15,616,000,000
20,084,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.